Relay Therapeutics Financial Overview
Relay Therapeutics's market cap is currently $1.35B. The company's EPS TTM is $-0.43; its P/E ratio is ―; Relay Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
